AC090154.1 | | | | | | |
| | Tissue enhanced | 0 |
ADM2 | Adrenomedullin 2 | | | | |
|
| | Tissue enhanced | 0 |
AFAP1L2 | Actin filament associated protein 1-like 2 | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ATP13A4 | ATPase type 13A4 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
BMP7 | Bone morphogenetic protein 7 | | | | | |
| Vesicles Nucleus Nucleoli | Tissue enhanced | 0 |
BMP8B | Bone morphogenetic protein 8b | | | | | N/A |
| | Tissue enhanced | 0 |
BTBD11 | BTB (POZ) domain containing 11 | | | | | |
| Nucleus but not nucleoli | Tissue enhanced | 0 |
C15orf56 | Chromosome 15 open reading frame 56 | | | | | N/A |
| | Tissue enhanced | 0 |
C1QL4 | Complement component 1, q subcomponent-like 4 | | | | | |
| | Tissue enhanced | 0 |
CD24 | CD24 molecule | | | | | |
| | Tissue enhanced | 0 |
CDON | Cell adhesion associated, oncogene regulated | | | | |
|
| | Tissue enhanced | 0 |
CLIC3 | Chloride intracellular channel 3 | | | | |
|
| Nucleus Cytoplasm | Tissue enhanced | 0 |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | | | | |
|
| Plasma membrane Golgi apparatus Vesicles | Tissue enhanced | 0 |
CNTN5 | Contactin 5 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
CNTN6 | Contactin 6 | | | | |
|
| | Tissue enhanced | 0 |
COL23A1 | Collagen, type XXIII, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
CRABP1 | Cellular retinoic acid binding protein 1 | | | | | N/A |
| | Tissue enhanced | 0 |
CTD-2313N18.7 | Beta-defensin 131-like precursor | | | | | N/A |
| | Tissue enhanced | 0 |
DCDC2 | Doublecortin domain containing 2 | | | | |
|
| Cytoplasm Nucleus | Tissue enhanced | 0 |
DMRT3 | Doublesex and mab-3 related transcription factor 3 | | | | | N/A |
| | Tissue enhanced | 0 |
DUOX1 | Dual oxidase 1 | | | | |
|
| | Tissue enhanced | 0 |
DUOXA1 | Dual oxidase maturation factor 1 | | | | |
|
| | Tissue enhanced | 0 |
EGR2 | Early growth response 2 | | | | | |
| | Tissue enhanced | 0 |
ENPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | | | | |
|
| | Tissue enhanced | 0 |
ESM1 | Endothelial cell-specific molecule 1 | | | | |
|
| | Tissue enhanced | 0 |
FAM150A | Family with sequence similarity 150, member A | | | | |
|
| | Tissue enhanced | 0 |
FAM167A | Family with sequence similarity 167, member A | | | | |
|
| | Tissue enhanced | 0 |
FAM189A2 | Family with sequence similarity 189, member A2 | | | | |
|
| | Tissue enhanced | 0 |
FNDC1 | Fibronectin type III domain containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
FRAS1 | Fraser extracellular matrix complex subunit 1 | | | | |
|
| Nucleoli | Tissue enhanced | 0 |
FREM2 | FRAS1 related extracellular matrix protein 2 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
FRMPD3 | FERM and PDZ domain containing 3 | | | | |
|
| | Tissue enhanced | 0 |
FSCN2 | Fascin actin-bundling protein 2, retinal | | | | | |
| | Tissue enhanced | 0 |
GAL3ST3 | Galactose-3-O-sulfotransferase 3 | | | | | |
| | Tissue enhanced | 0 |
GLIS3 | GLIS family zinc finger 3 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
GOLGA8J | Golgin A8 family, member J | | | | | |
| | Tissue enhanced | 0 |
GOLGA8M | Golgin A8 family, member M | | | | | |
| | Tissue enhanced | 0 |
GOLGA8O | Golgin A8 family, member O | | | | | |
| | Tissue enhanced | 0 |
GOLGA8Q | Golgin A8 family, member Q | | | | | |
| | Tissue enhanced | 0 |
GOLGA8R | Golgin A8 family, member R | | | | | |
| | Tissue enhanced | 0 |
GPR61 | G protein-coupled receptor 61 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
GRIK2 | Glutamate receptor, ionotropic, kainate 2 | | | | |
|
| | Tissue enhanced | 0 |
ID4 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | | | | |
|
| Nucleus | Tissue enhanced | 0 |
IPCEF1 | Interaction protein for cytohesin exchange factors 1 | | | | |
|
| | Tissue enhanced | 0 |
IQCA1 | IQ motif containing with AAA domain 1 | | | | |
|
| Nucleus | Tissue enhanced | 0 |
IRS4 | Insulin receptor substrate 4 | | | | |
|
| | Tissue enhanced | 0 |
ISM1 | Isthmin 1, angiogenesis inhibitor | | | | |
|
| | Tissue enhanced | 0 |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | | | | |
|
| | Tissue enhanced | 0 |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | | | | |
|
| Nucleus Cytoplasm | Tissue enhanced | 0 |
KCNIP3 | Kv channel interacting protein 3, calsenilin | | | | |
|
| | Tissue enhanced | 0 |